GenDx is celebrating 20 years of innovation and excellence in transplant diagnostics
This year, GenDx celebrates 20 years and two decades of dedication to transplant diagnostics. What started as a small team of scientists with a shared vision has grown into a globally recognized leader, driven by innovation, collaboration, and a commitment to improving the quality of life and survival of transplant patients.
The beginning
On January 1st, 2004, Erik Rozemuller and Wietse Mulder began shaping Genome Diagnostics. After a year of planning, GenDx was officially established on March 1st, 2005. They started as a small team of dedicated scientists working to develop better tools for high-resolution HLA typing. From the beginning, collaboration and education were as important as innovation. GenDx knew that true progress in transplantation wouldn’t come from technology alone but also from sharing knowledge with the healthcare professionals who rely on it every day.
Growing with purpose
Over the years, GenDx has evolved, but their core mission has remained the same. In 2013, they introduced NGSgo reagents and NGSengine software, making high-resolution sequencing for HLA typing more accessible to labs worldwide. As their expertise grew, GenDx expanded the focus to include chimerism monitoring with NGStrack and TRKengine, helping transplant teams detect complications earlier.
In 2022, they became part of Eurobio Scientific, a step that allowed us to strengthen our impact globally while remaining true to their values. Today, GenDx is proud to be part of a broader network of diagnostics specialists, with affiliates across Europe and other parts of the world.
A global leader in transplant diagnostics
GenDx is one of the top tier companies in transplant diagnostics worldwide, recognized for their commitment to research, education, and high-quality solutions. GenDx has grown into a team of over 110 colleagues from 20 different nationalities, bringing diverse perspectives and expertise to its work. This would not be possible without the support and commitment from their customers and partners.
Laigo Bio at Utrecht Science Park raises €11.5 million in investments
Laigo Bio, a start-up located at Utrecht Science Park in the Life Sciences Incubator building, announced today that it has raised €11.5 million in investments from a large number of leading investors.
Ronald McDonald House Utrecht presents plans for new, larger House with 50 rooms
Ronald McDonald House Utrecht is building for the future. At Utrecht Science Park, next to the Wilhelmina Children’s Hospital and within walking distance of the Princess Máxima Center, Ronald McDonald House Utrecht has advanced plans to build a brand new, sustainable House with 50 guest rooms. Preparations are well underway, and construction is scheduled to begin in the second half of 2026. The goal is to open the new House sometime in 2028. This expansion will allow the House to offer more families of seriously ill or care-intensive children a warm home, allowing them to be close to their sick child day and night.
French honour for nutrition scientist Johan Garssen
Researcher Johan Garssen has been appointed Officier in the Ordre du Mérite agricole by the French government. He receives this prestigious honor for his exceptional contributions to agriculture, nutrition, health and international collaboration. The decoration was presented today by the French Ambassador to the Netherlands.
